Cover_(rs-3).p65
in children, 74environmental control measures and, 42
Note: Page numbers in
italics indicate figures.
Allergic reactions. See also
Inflammatory cascade.
Page numbers followed by t refer to tables.
Numbers preceded by CP indicate Color Plates.
ABRS. See
Bacterial rhinosinusitis, acute.
causes of, 15t, 32-33. See also
Allergens.
chronic, 135. See also
Rhinosinusitis, chronic.
skin tests in. See
Allergy skin tests.
Adolescents, adenoid hypertrophy in, 13, 27
Afrin. See
Oxymetazoline nasal spray.
Age. See also
Adolescents; Children.
inflammatory cascade in, 21-22,
22-24, 24-26
Air-fluid levels, in sinuses, CP4, CP7, CP8, CP9,
110, 139, 141
intranasal vs oral antihistamines for, 54-55
Alkylamines. See also specific drugs.
treatment of. See
Rhinitis treatment.
Allergic Rhinitis and Its Impact on Asthma (ARIA), 38, 68
Allergy and Asthma Network/Mothers of Asthmatics, Inc.
dust mites as, 25t, 30-31, 34, 40, 40t, 80
American Academy of Allergy, Asthma, and Immunology (AAAAI),
American Academy of Otolaryngic Allergy (AAOA), 147
American Academy of Otolaryngology Head and Neck Surgery
American Academy of Pediatrics (AAP), 148
American College of Allergy and Immunology (ACAI), 148
American Rhinologic Society (ARS), 148-149
dosage of, 118t, 121,
122-123, 126-127, 128t, 130t
susceptibility/resistance to, 104t, 124t, 141
Anti-immunoglobulin E monoclonal antibody
dosage of, 118t, 121,
122, 126, 128t-130t, 132
against
Haemophilus influenzae, 101, 103, 104t
Anti-inflammatory drugs, in pregnancy, 76t-77t
against
Moraxella catarrhalis, 103
against
Streptococcus pneumoniae, 104t, 124t-125t
Angiotensin-converting enzyme inhibitors, 31
Animal allergens, extracts for allergy shots, 80
Astelin Nasal Spray. See
Azelastine nasal spray.
alteration of bacterial target or binding site in, 99
β-lactamase production and, 98-99, 101,
102, 103
selection of, nasal endoscopy in, CP3, 108
Anticholinergic side effects, of oral antihistamines, 48
Antigen-presenting cell, 21,
22-23
Antihistamines. See also specific drugs.
Asthma and Allergy Foundation of America (AAFA), 149
Atrovent. See
Ipratropium bromide nasal spray.
Augmentin. See
Amoxicillin/clavulanate.
Autumn, environmental allergens in, 25t, 30
Avelox (moxifloxacin). See
Moxifloxacin.
Azelastine nasal spray (Astelin Nasal Spray)
Beconase AQ. See
Beclomethasone nasal spray.
Bed covers, in dust mite avoidance, 40t, 41
-lactam antibiotics, allergic reactions to, 132-133
in β-lactam allergic patients, 121, 128t-129t, 132
-lactamase production, 98-99, 101,
102, 103
Birth control pills, 31Blood pressure medications, 15t, 31
Bacteria, translocation into sinus cavities, 97
Bacterial rhinosinusitis, acute (ABRS). See also
Rhinosinusitis;
antibiotic resistance in, 98-99, 101, 103, 104t-105t
Budesonide nasal spray (Rhinocort AQ), 44t
orbital invasion by, CP11, 142,
143-144
treatment of, 117, 139-140. See also specific drugs and drug types.
unilateral, computed tomography of,
105
Bactrim. See
Trimethoprim/sulfamethoxazole (TMP/SMX).
Beclomethasone nasal spray (Beconase AQ, Vancenase)
for ABRS, 121,
122, 124t, 128t, 132
against
Haemophilus influenzae, 101, 103, 104t
against
Moraxella catarrhalis, 103
penicillin cross-reactivity with, 132-133
against
Streptococcus pneumoniae, 104t
amoxicillin or clindamycin with,
123, 127t, 130t
indications for, 101, 103,
122, 124t
susceptibility/resistance to, 101, 103, 104t, 124t
Ceftin (cefuroxime). See
Cefuroxime.
for ABRS,
122, 124t-126t, 128t-129t
Clavulanate. See
Amoxicillin/clavulanate.
Cephalosporins, drug cross-reactivity with, 132-133
rifampin with, 124t-125t, 127t, 129t-130t
of intranasal corticosteroids, 56-57, 66-69
in chronic rhinosinusitis, 136t, 137,
138
drugs for, 117, 120t, 121, 128t-131t, 132
of sinus opacification, CP9, 140-141,
143-144
in sinusitis diagnosis, 109-110,
111-115
Congenital abnormalities, chronic rhinosinusitis and, 135
eczema in, adult atopic dermatitis and, 29
rhinosinusitis in, diagnosis of, 107, 109
clinically distinguishing factors of, 65t
Corticosteroid nasal sprays
(continued)
Desloratadine (Clarinex)
(continued)
Dexamethasone nasal spray, 44t, 61, 64, 65t
leukotriene receptor antagonists vs, 72-73
Diagnosis and Management of Rhinitis: Parameter Documents of
the Joint Task Force on Practice Parameters in Allergy, Asthma,
Cromolyn sodium ophthalmic drops (Opticrom), 74, 75t
Cromolyn sodium solution (Nasalcrom), 44t
in β-lactam allergy, 121,
123, 127t
Dristan Long-Lasting. See
Oxymetazoline nasal spray. Dristan Nasal (phenylephrine HCl/pheniramine maleate), 59t
Decongest. See
Oxymetazoline nasal spray.
Duration. See
Phenylephrine nasal spray.
rebound congestion from, 31, 57recommended duration of use, 57
Eczema, childhood, adult atopic dermatitis and, 29
Endoscopic sinus surgery, computer-aided, 137,
138
Endoscopy, nasal. See
Nasal endoscopy .
over-the-counter, dosage and delivery of, 58t-59t
Environmental allergens, seasonal, 25t, 28t, 30-31, 92t, 142-145.
Environmental chemicals/pollutants, chronic rhinosinusitis and, 135
Enzyme-linked immunosorbent assay (ELISA), for IgE, 35-36
Eosinophil(s), in inflammatory cascade, 21-22,
22-23
in nonallergic rhinitis. See
Nonallergic rhinitis with eosinophilia
Folate inhibitors, 104t, 119t. See also
Trimethoprim/
susceptibility/resistance to, 105t, 124t-127t
Gemifloxacin (Factive), 105t, 120tGenetic abnormalities, chronic rhinosinusitis and, 135
Geographic locations, allergen variation in, 30
Granulocyte-macrophage colony-stimulating factor, in early- and
Fall, environmental allergens in, 25t, 30
Granulomatous disease, in nasal obstruction, 27, 28t, 92t
duration of action, 49effectiveness of, 50, 52-53, 55-56
antibiotic resistance/susceptibility of, 99, 101, 103, 104t, 124t-125t,
β-lactamase production by, 99,
102, 103
as rhinosinusitis pathogen, 97,
98-99
Flonase. See
Fluticasone nasal spray.
Flunisolide nasal spray (Nasalide, Nasarel), 44t
Heart, antihistamine adverse effects on, 49-50, 51t
High-efficiency particulate air (HEPA) filters, 41
Fluoroquinolones, against
Streptococcus pneumoniae and
Haemophilus influenzae, 101, 103, 105t,
106, 123t, 126t
Immunodeficiency, chronic rhinosinusitis in, 135
pharmacokinetics of, 65tpotency of, 61, 63t, 63-64in pregnancy, 76t-77t
Immunoglobulin E (IgE). See also
Anti-immunoglobulin E
Laboratory tests, in rhinitis diagnosis, 33-36
monoclonal antibody; Omalizumab.
in treating allergic rhinitis, 44t-45t, 72-73, 145
in early and late phase allergic response,
24
in inflammatory cascade, 21-22,
22-24
In vitro assays. See
Blood tests.
Inflammatory cascade, in allergic rhinitis, 21-22,
22-24, 24-26
in early- and late-phase allergic response,
24, 26
in inflammatory cascade, 21-22,
23
Ipratropium bromide nasal spray (Atrovent), 44t
Macrophage, in inflammatory cascade, 21,
22-23
Magnetic resonance imaging, in chronic rhinosinusitis, 136t, 137Major basic protein,
23
in early- and late-phase allergic response,
24
in inflammatory cascade, 21-22,
22-23, 24
opacification of, CP5, CP9, 141,
143
Ketotifen fumarate (Zaditor), 74, 75t, 78
drugs for, 26. See also
Decongestants.
Mometasone nasal spray (Nasonex), 44t, 61
Nasal drainage, in chronic rhinosinusitis, CP10, 141
in chronic rhinosinusitis diagnosis, 135, 136t
Monoclonal antibody, against IgE, 74-75. See also
Omalizumab.
with Gram’s stain, in detecting sinus bacteria, 97
in rhinitis. See
Structural rhinitis.
antibiotic resistance/susceptibility of, 99, 101, 103
as rhinosinusitis pathogen, 97,
98-99
susceptibility/resistance to, 105t,
123, 125t
Mucociliary dysfunction, chronic rhinosinusitis and, 135
inflammation of, in polyposis etiology, 19
Mucosal barrier, inhaled allergen penetration of, 21
Nasal septal deformity. See
Septal deviation.
Nasal spray. See
Decongestants, as nasal sprays.
Nasal trauma, structural rhinitis and, 15t
NARES. See
Nonallergic rhinitis with eosinophilia syndrome.
Nasalcrom. See
Cromolyn sodium solution.
Nasacort. See
Triamcinolone acetonide nasal spray.
Nasalide. See
Flunisolide nasal spray.
Nasarel. See
Flunisolide nasal spray.
Nasonex. See
Mometasone nasal spray.
Oxymetazoline nasal spray (Afrin, Decongest, Dristan Long-Lasting,
National Ambulatory Medical Care Survey, 11
Neo-Synephrine. See
Oxymetazoline nasal spray; Phenylephrine
Nonallergic rhinitis with eosinophilia syndrome (NARES), 92t
cross-reactivity with cephalosporins, 132-133
cross-resistance with other antibiotic classes, 103t
Streptococcus pneumoniae resistance to, 99, 101,
102, 104t-105t,
123
Northern United States, seasonal allergens in, 25t
endoscopy of. See
Nasal endoscopy.
Phenylephrine HCl/naphazoline HCl/pyrilamine maleate
Nostrilla. See
Oxymetazoline nasal spray.
Phenylephrine HCl/pheniramine maleate (Dristan Nasal), 59t
Phenylephrine HCl/pyrilamine maleate (MYCl Spray), 59t
Phenylephrine nasal spray (Duration, Neo-Synephrine, Nostril,
Occupational irritants. See
Workplace.
Opacification, of sinuses, CP5, CP7, CP9, 140-141,
143-144
Opticrom (cromolyn sodium ophthalmic drops), 74, 75t
Oral contraceptives, rhinitis medicamentosa from, 31
Orbital abscess, from ABRS, CP11, 142,
143-144
asthma/allergy medications in, 75, 76t-77t
dosage of, 58tduration of action, 44t, 58t
treatment of. See
Rhinitis treatment.
Pseudoephedrine (Novafed, Pseudogest, Sudafed), 44t
types of, 14t-15t, 92t. See also specific type, eg,
Allergic rhinitis;
Pyrilamine maleate, in hybrid intranasal spray, 59t
factors associated with, 15tsymptoms of, 14t
pharmacologic. See also specific drugs or drug types.
in sinus air-fluid level determination, CP4, 108-109
anticholinergics in, 44t-45t, 70, 71t, 72
in sinusitis diagnosis, 108-109,
110
corticosteroids in, 43, 44t-45t, 60-61, 63, 65t, 66-69
comparative antihistamine effectiveness against, 53-54, 67
inhaled antihistamines in, 43, 44t-45t, 54-55
oral antihistamines in, 43, 44t-47t, 45, 48-54, 54-55
Respiratory infection, viral. See
Viral upper respiratory infection.
Rhinocort AQ. See
Budesonide nasal spray.
Rhinitis. See also
Rhinosinusitis.
Rhinoscopy, in loss of sense of smell/taste, 27
Rhinosinusitis. See also
Rhinitis; Sinusitis.
acute bacterial. See
Bacterial rhinosinusitis, acute.
Sinus and Allergy Health Partnership (SAHP), 149
Sinusitis, 92t. See also
Bacterial rhinosinusitis, acute; Rhinosinusitis.
treatment of, 15t, 110, 117. See also specific drugs and drug types.
antibiotics in, 11, 15t, 111, 117, 124t-125t
bilateral, computed tomography of,
106
diagnosis of, computed tomography in, 109-110,
115
Skin tests. See
Allergy skin tests.
clindamycin with, 124t-125t, 127t, 129t-130t
asthma symptoms and, 41chronic rhinosinusitis and, 135
in environmental allergens, 25t, 28t, 30-31, 92t
Spring, environmental allergens in, 25t, 30
Staphylococcus pyogenes, as ABRS pathogen, 97,
99
Steroids. See
Corticosteroid nasal spray.
antibiotic susceptibility of, 97, 99, 101, 103, 104t-105t, 124t-125t,
other antibiotic class cross-resistance in, 103t
Septra. See
Trimethoprim/sulfamethoxazole (TMP/SMX).
nasal polyps in, 27. See also
Nasal polyps.
septal deformity in. See
Septal deviation.
air-fluid levels in, CP4, CP7, CP8, CP9, 139, 141
Summer, environmental allergens in, 25t, 30
Sympathomimetics. See
Corticosteroid nasal spray.
Ultrasonography, in rhinosinusitis diagnosis, 108
in early- and late-phase allergic response, 26
in inflammatory cascade, 21-22,
22-24
TMP/SMX. See
Trimethoprim/sulfamethoxazole.
Toothache, maxillary, 107Torsade de pointes, 49
Vancenase. See
Beclomethasone nasal spray.
Triamcinolone acetonide nasal spray (Nasacort, Tri-Nasal Spray), 44t
Vicks-Sinex. See
Phenylephrine nasal spray.
Trimethoprim/sulfamethoxazole (TMP/SMX) (Bactrim, Septra)
Wegener granulomatosis, in nasal obstruction, 27, 28t, 92t
Tri-Nasal Spray (triamcinolone acetonide). See
Triamcinolone
Winter, environmental allergens in, 25t, 30
in early- and late-phase allergic response,
24, 25
lost time at, from chronic rhinitis/sinusitis, 11
Xolair. See
Omalizumab. Xylometazoline nasal spray (Otrivin, Sinex)
dosage of, 58tduration of action, 44t, 58trebound congestion from, 57
Zaditor (ketotifen fumarate), 74, 75t, 78Zafirlukast, 76t-77tZileuton, 76t-77t, 78Zithromax (azithromycin), 119t
in β-lactam allergy, 121, 128t-129t, 132in children, 128t-129tindications for, 121, 124tsusceptibility/resistance to, 104t, 124t
Source: https://www.pcibooks.com/files/index/27/27.pdf
Revista Latinoamericana de Ortodoncia y Odontopediatría Depósito Legal Nº: pp200102CS997 - ISSN: 1317-5823 – www.ortodoncia.ws P á g i n a | 1 ESTUDIO DESCRIPTIVO DE SIGNOS Y SÍNTOMAS, EN NIÑOS Y ADOLESCENTES, CON TRASTORNOS TÉMPOROMANDIBULARES Para efectos de referencia bibliográfica este trabajo debe ser citado de la siguiente manera: Wurgaft R., Rappoport K., Zeñ
Chace Avenue, Willenhall, Coventry, CV3 3AD Inspection dates Overall effectiveness This inspection: Requires improvement Summary of key findings for parents and pupils This is a school that requires improvement. It is not good because The quality of teaching requires improvement Skills learnt in mathematics are not regularly in mathematics in Years 1 to 6. Work doe
A |
B |
C |D |E |
F |
G |H |I |
J |
K |
L |
M |N |O |
P |
Q |
R |
S |
T |U |V |
W |
X |
Y |
Z |0-9 |